Ovid Therapeutics (OVID) Debt to Equity (2019 - 2020)
Ovid Therapeutics filings provide 2 years of Debt to Equity readings, the most recent being $0.06 for Q4 2020.
- Quarterly Debt to Equity rose 1212.65% to $0.06 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $0.06 through Dec 2020, up 1212.65% year-over-year, with the annual reading at $0.06 for FY2020, 1212.65% up from the prior year.
- Debt to Equity hit $0.06 in Q4 2020 for Ovid Therapeutics, up from $0.0 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.06 in Q4 2020 and bottomed at $0.0 in Q4 2019.